Evolus (EOLS) Goodwill & Intangibles (2017 - 2026)
Evolus (EOLS) posted Goodwill & Intangibles of $67.9 million for Q1 2026, down 1.88% on a QoQ basis from $69.2 million in Q4 2025, and down 3.71% year-over-year from $70.6 million in Q1 2025.
Evolus (EOLS) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Evolus' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $67.9 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 3.71% year-over-year to $67.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.9 million (down 3.71% YoY) and the FY2025 annual result came in at $69.2 million, down 1.02% from the prior year.
- Goodwill & Intangibles was $67.9 million for Q1 2026 at Evolus, down from $69.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $71.2 million in Q1 2022 and bottomed at $67.5 million in Q2 2024.
- A 5-year average of $69.2 million and a median of $69.2 million in 2025 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles dropped 4.73% — and 2025, when it gained 4.55%.
- Evolus' Goodwill & Intangibles stood at $69.8 million in 2022, then decreased by 2.13% to $68.3 million in 2023, then rose by 2.41% to $70.0 million in 2024, then slipped by 1.02% to $69.2 million in 2025, then retreated by 1.88% to $67.9 million in 2026.
- Business Quant data shows EOLS's Goodwill & Intangibles at $67.9 million in Q1 2026, $69.2 million in Q4 2025, and $69.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.95 Mn |
| Dec 31, 2025 | 69.25 Mn |
| Sep 30, 2025 | 69.93 Mn |
| Jun 30, 2025 | 70.56 Mn |
| Mar 31, 2025 | 70.57 Mn |
| Dec 31, 2024 | 69.96 Mn |
| Sep 30, 2024 | 67.80 Mn |
| Jun 30, 2024 | 67.48 Mn |
| Mar 31, 2024 | 67.80 Mn |
| Dec 31, 2023 | 68.32 Mn |
| Sep 30, 2023 | 67.71 Mn |
| Jun 30, 2023 | 68.42 Mn |
| Mar 31, 2023 | 69.14 Mn |
| Dec 31, 2022 | 69.81 Mn |
| Sep 30, 2022 | 70.32 Mn |
| Jun 30, 2022 | 70.62 Mn |
| Mar 31, 2022 | 71.24 Mn |
| Dec 31, 2021 | 71.83 Mn |
| Sep 30, 2021 | 72.68 Mn |
| Jun 30, 2021 | 73.52 Mn |